Atomwise Revenue and Competitors

License our Company Data API

$176.6M

Total Funding

Estimated Revenue & Valuation

Atomwise's estimated annual revenue is currently $15.7M per year.(i)
Atomwise received $45.0M in venture funding in March 2018.
Atomwise's estimated revenue per employee is $201,000
Atomwise's total funding is $176.6M.

Employee Data

Atomwise has 78 Employees.(i)
Atomwise grew their employee count by -26% last year.

Atomwise's People

Name	Title	Email/Phone
1 Izhar Wallach	Co-Founder and CTO	Reveal Email/Phone
2 Jeffrey Cerio	General Counsel and Corporate Secretary	Reveal Email/Phone
3 Yan Zhao	VP, FINANCE	Reveal Email/Phone
4 Karthik Sriniva...	VP, Preclinical Sciences	Reveal Email/Phone
5 Henry Van	SVP, Head Machine Learning Cheminformatics & Research	Reveal Email/Phone
6 Sam Eckert	Director, Engineering	Reveal Email/Phone
7 Christian Laggn...	Associate Director, CADD	Reveal Email/Phone
8 Steph Simmons	SENIOR DIRECTOR, BIZ OPS & SPECIAL PROJECTS	Reveal Email/Phone
9 Lien Ngo	Director, Program Management R&D	Reveal Email/Phone
10 Aryan Pedawi	Director, ML Research	Reveal Email/Phone

Atomwise Competitors & AlternativesAdd Company

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Schrödinger	$124.8M	910	1%	$567.2M	$2.2B
#2 InCrowd	$5.3M	68	11%	$3M	N/A
#3 DrugPatentWatch...	$1.4M	7	N/A	N/A	N/A
#4 Thermo Fisher S...	$39060M	98035	0%	$30 b	$234.4B
#5 DrugDev	$130.9M	651	N/A	N/A	N/A
#6 Document Soluti...	$25.7M	161	N/A	N/A	N/A
#7 Advera Health A...	$1.2M	14	N/A	N/A	N/A
#8 Naked Biome	$0.9M	6	N/A	N/A	N/A
#9 Bruker Corporat...	$2360M	4804	7%	$22.5M	$10.7B
#10 Chemical Comput...	$12.2M	79	N/A	N/A	N/A
#11 Certara	$275.4M	1554	7%	N/A	$4.4B
#12 Optibrium	$11.2M	72	3%	N/A	N/A
#13 Olympus Life Sc...	$12.6M	57	-15%	N/A	N/A
#14 Adjility Inform...	$0.1M	4	N/A	N/A	N/A
#15 De Novo Softwar...	$2.7M	27	N/A	N/A	N/A
#16 Genedata	$87.4M	564	N/A	N/A	N/A
#17 Gritstone Oncol...	$46.5M	233	2%	$396M	$424.9M
#18 American Gene T...	$8.4M	54	N/A	N/A	N/A
#19 Eidogen-Sertant...	$0.5M	9	N/A	N/A	N/A
#20 European Bioinf...	$173.8M	856	37%	N/A	N/A

Add Company

Show More Pharma Companies

What Is Atomwise?

Atomwise uses Deep Learning Neural Networks to help discover new medicines. Atomwise achieves the world's best results for new drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise predicts drug candidates for pharmaceutical companies, startups, and research institutions.

keywords:Analytics,Big Data,Biotechnology,Healthcare,Pharmaceuticals

$176.6M

Total Funding

Number of Employees

$15.7M

Revenue (est)

-26%

Employee Growth %

N/A

Valuation

Y Combinator

Accelerator

Atomwise News

2022-04-17 - Artificial Intelligence in Medicine Market Future Growth with ...

Globavir Biosciences, Inc. GNS Healthcare Flatiron Health Benevolent AI Atomwise Verge Genomics Cloud Pharmaceuticals Recursion Pharmaceuticals.

2022-04-17 - Artificial Intelligence In Healthcare Service Market Regional ...

... Regional Report 2022: Trade Insights, Commodity Review For Forecasts To 2030: Ibm, Microsoft, Enlitic, Arterys, Atomwise, Freenome.

2022-04-17 - AI-based drug discovery with Atomwise and WEKA Data ...

On the forefront is Atomwise, with its AtomNet® platform. It has succeeded in finding small molecule hits for more undruggable targets than any...

2021-01-12 - StemoniX to Participate in Biotech Showcase(TM) Digital 2021

Maple Grove, Minnesota--(Newsfile Corp. - January 11, 2021) - StemoniX, a biotech company changing how new drugs are discovered, announced today their participation at the 2021 Biotech Showcase™ being held January 11-15th as part of OrganAi, a joint venture between StemoniX and Atomwise. The com ...

2020-10-06 - Atomwise : Receives a $2.3M Grant to Develop New Therapies for Drug Resistant Malaria and Tuberculosis

Atomwise, the leader in using artificial intelligence (AI) for small molecule drug discovery, announced today $2.3M in grant funding for AI-based discovery of antimalarial and anti-tuberculosis therapies from the Bill & Melinda Gates Foundation. The grant funding will be used to discover novel c ...